Yunxia Zhu

1.3k total citations
55 papers, 907 citations indexed

About

Yunxia Zhu is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Yunxia Zhu has authored 55 papers receiving a total of 907 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Cancer Research, 27 papers in Molecular Biology and 22 papers in Oncology. Recurrent topics in Yunxia Zhu's work include MicroRNA in disease regulation (18 papers), Cancer-related molecular mechanisms research (16 papers) and Circular RNAs in diseases (13 papers). Yunxia Zhu is often cited by papers focused on MicroRNA in disease regulation (18 papers), Cancer-related molecular mechanisms research (16 papers) and Circular RNAs in diseases (13 papers). Yunxia Zhu collaborates with scholars based in China and Sweden. Yunxia Zhu's co-authors include Qiliang Peng, Li Zou, Peipei Shen, Min‐Bin Chen, Yuntian Shen, Ye Tian, Pei‐Hua Lu, Yi Shen, Xueli Zhang and Ye Tian and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Yunxia Zhu

51 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yunxia Zhu China 16 473 446 330 159 112 55 907
Véronique Verrièle France 14 381 0.8× 296 0.7× 400 1.2× 154 1.0× 233 2.1× 35 923
Su Hwan Kang South Korea 14 358 0.8× 226 0.5× 452 1.4× 155 1.0× 160 1.4× 59 842
Antonino Iaccarino Italy 18 333 0.7× 376 0.8× 394 1.2× 123 0.8× 321 2.9× 58 1.0k
Sally A. Mullany United States 15 175 0.4× 381 0.9× 245 0.7× 282 1.8× 88 0.8× 22 899
Masafumi Inokuchi Japan 16 210 0.4× 178 0.4× 241 0.7× 114 0.7× 73 0.7× 61 663
Kazutaka Narui Japan 12 275 0.6× 153 0.3× 215 0.7× 130 0.8× 121 1.1× 81 543
Gennaro Limite Italy 11 320 0.7× 146 0.3× 392 1.2× 91 0.6× 80 0.7× 32 674
Tilmann Lantzsch Germany 14 209 0.4× 237 0.5× 294 0.9× 172 1.1× 101 0.9× 26 819
Stephen Rohan United States 15 268 0.6× 459 1.0× 133 0.4× 177 1.1× 509 4.5× 28 879
Magdalena Chechlińska Poland 15 197 0.4× 246 0.6× 370 1.1× 80 0.5× 113 1.0× 38 790

Countries citing papers authored by Yunxia Zhu

Since Specialization
Citations

This map shows the geographic impact of Yunxia Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunxia Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunxia Zhu more than expected).

Fields of papers citing papers by Yunxia Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunxia Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunxia Zhu. The network helps show where Yunxia Zhu may publish in the future.

Co-authorship network of co-authors of Yunxia Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Yunxia Zhu. A scholar is included among the top collaborators of Yunxia Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunxia Zhu. Yunxia Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ma, Jiayan, Ming Cheng, Yong Wang, et al.. (2025). Comprehensive multi-omics analysis of bile acid metabolism in hepatocellular carcinoma: implications for prognosis, immune microenvironment, and therapeutic resistance. Clinical & Translational Oncology. 27(12). 4430–4449. 1 indexed citations
3.
4.
Peng, Qiliang, et al.. (2024). LC–MS metabolomics analysis of serum metabolites during neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Clinical & Translational Oncology. 26(12). 3150–3168. 1 indexed citations
5.
Zhu, Yunxia, et al.. (2024). Homeownership and public sector employment: Evidence from the removal of home purchase restrictions in China. Journal of Housing Economics. 67. 102041–102041. 1 indexed citations
6.
Peng, Qiliang, et al.. (2023). CYFIP2 serves as a prognostic biomarker and correlates with tumor immune microenvironment in human cancers. European journal of medical research. 28(1). 364–364. 6 indexed citations
7.
8.
Yang, Yongqiang, Qi Guo, Qiliang Peng, et al.. (2020). Comparing hypofractionated to conventional fractionated radiotherapy in postmastectomy breast cancer: a meta-analysis and systematic review. Radiation Oncology. 15(1). 17–17. 53 indexed citations
9.
Peng, Qiliang, Ming Cheng, Ting Li, et al.. (2020). Integrated characterization and validation of the prognostic significance of microRNA-200s in colorectal cancer. Cancer Cell International. 20(1). 56–56. 3 indexed citations
10.
Peng, Qiliang, et al.. (2020). Biomarker roles identification of miR-106 family for predicting the risk and poor survival of colorectal cancer. BMC Cancer. 20(1). 506–506. 19 indexed citations
11.
Peng, Qiliang, et al.. (2020). Biomarker implication of kallikrein-related peptidases as prognostic tissue substrates of poor survival in colorectal cancer. Cancer Cell International. 20(1). 260–260. 2 indexed citations
12.
Hu, Xiao, Qiliang Peng, Jiahao Zhu, et al.. (2019). Identification of miR-210 and combination biomarkers as useful agents in early screening non-small cell lung cancer. Gene. 729. 144225–144225. 12 indexed citations
13.
14.
Hu, Yan, Xiaoqian Liu, Jin Huang, et al.. (2016). Incidence and risk factors for breast cancer-related lymphedema: a retrospective cohort study. Zhonghua fangshe zhongliuxue zazhi. 25(10). 1083–1087. 1 indexed citations
15.
Zeng, Ping, Peng Zhang, Li-Na Zhou, et al.. (2016). TMPRSS4 as an emerging potential poor prognostic factor for solid tumors: A systematic review and meta-analysis. Oncotarget. 7(46). 76327–76336. 8 indexed citations
16.
Liu, Fenghua, Yan Hu, Peipei Shen, et al.. (2016). Lymphedema after surgical treatment for breast cancer: a 2-year follow-up study of incidence and risk factors. Zhonghua fangshe zhongliuxue zazhi. 25(6). 593–597. 1 indexed citations
17.
Yu, Qi, et al.. (2014). 125I particle implantation combined with chemoradiotherapy to treat advanced pancreatic cancer. British Journal of Radiology. 87(1036). 20130641–20130641. 5 indexed citations
18.
Hu, Xiao, et al.. (2013). Copy number variation at 6q13 is associated with lung cancer risk in a Han Chinese population. Experimental Lung Research. 39(10). 427–433. 5 indexed citations
19.
Chen, Min‐Bin, Yunxia Zhu, Junying Xu, et al.. (2012). Value of TP53 Status for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer: A Meta-Analysis. PLoS ONE. 7(6). e39655–e39655. 32 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Véronique Verrièle Breakdown of academic impact, for papers by Su Hwan Kang Breakdown of academic impact, for papers by Antonino Iaccarino Breakdown of academic impact, for papers by Sally A. Mullany Breakdown of academic impact, for papers by Masafumi Inokuchi Breakdown of academic impact, for papers by Kazutaka Narui Breakdown of academic impact, for papers by Gennaro Limite Breakdown of academic impact, for papers by Tilmann Lantzsch Breakdown of academic impact, for papers by Stephen Rohan Breakdown of academic impact, for papers by Magdalena Chechlińska
Rankless by CCL
2026